XR Securities’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,000
Closed -$531K 449
2023
Q4
$531K Sell
1,000
-800
-44% -$387K 0.02% 258
2023
Q3
$911K Buy
1,800
+400
+29% +$213K 0.07% 176
2023
Q2
$730K Buy
+1,400
New +$755K 0.04% 194
2023
Q1
Sell
-1,000
Closed -$551K 563
2022
Q4
$551K Buy
+1,000
New +$530K 0.05% 257
2019
Q2
Sell
-10,100
Closed -$20K 364
2019
Q1
$20K Buy
+10,100
New +$2.51M ﹤0.01% 227

Other funds holding TMO

XR Securities's TMO Position: Q2 2021 in Review

XR Securities sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 492 shares — an estimated $225K sold.

XR Securities first reported a position in TMO in Q4 2018 and held it in 5 quarters. The position peaked at $814K in Q4 2020. 2,075 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • XR Securities reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
  • XR Securities sold 492 Thermo Fisher Scientific shares in Q2 2021, an estimated $225K.
  • XR Securities first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 5 quarters.
  • XR Securities's Thermo Fisher Scientific position peaked at $814K in Q4 2020.
  • 2,075 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on XR Securities's 13F filing for Q2 2021, filed 26 Jul 2021.